Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221
Patient Information Leaflet last updated on the eMC: 08/02/2010
PIL Pro-Epanutin Concentrate for Infusion / Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/02/2010 and displayed until Current
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
Updated on 29/01/2009 and displayed until 08/02/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/01/2009 and displayed until 29/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change due to user-testing of patient information
Updated on 23/01/2006 and displayed until 20/01/2009
Reasons for adding or updating:
  • Change of licence holder
Updated on 25/01/2005 and displayed until 23/01/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   fosphenytoin sodium


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk